A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.
- DOI
- 10.3389/fphar.2018.00022
- Published
- 2018
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2018.00022,
title = {A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.},
author = {Xin Z and Jin C and Chao L and Zheng Z and Liehu C and Panpan P and Weizong W and Xiao Z and Qingjie Z and Honggang H and Longjuan Q and Xiao C and Jiacan S},
year = {2018},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2018.00022},
url = {https://doi.org/10.3389/fphar.2018.00022}
}RIS
TY - JOUR TI - A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5. AU - Xin Z AU - Jin C AU - Chao L AU - Zheng Z AU - Liehu C AU - Panpan P AU - Weizong W AU - Xiao Z AU - Qingjie Z AU - Honggang H AU - Longjuan Q AU - Xiao C AU - Jiacan S PY - 2018 JO - Frontiers in pharmacology DO - 10.3389/fphar.2018.00022 UR - https://doi.org/10.3389/fphar.2018.00022 ER -
APA
Z, X., C, J., L, C., Z, Z., C, L., P, P., W, W., Z, X., Z, Q., H, H., Q, L., C, X., & S, J. (2018). A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2018.00022
Source records
- pubmed · retrieved 2026-09-24T18:49:36.915Z
- europe-pmc · retrieved 2026-09-24T18:49:36.928Z